Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
36.66
-1.10 (-2.91%)
At close: Mar 3, 2026, 4:00 PM EST
36.70
+0.04 (0.10%)
After-hours: Mar 3, 2026, 7:59 PM EST
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Sep 30, 2025 | 33.89B | 12.86B | 3.16B |
| Jun 30, 2025 | 33.70B | 12.49B | 3.13B |
| Mar 31, 2025 | 33.48B | 11.47B | 2.98B |
| Dec 31, 2024 | 32.67B | 10.30B | 2.95B |
| Sep 30, 2024 | 31.32B | 8.69B | 2.77B |
| Jun 30, 2024 | 30.48B | 7.66B | 2.66B |
| Mar 31, 2024 | 28.85B | 7.09B | 2.68B |
| Dec 31, 2023 | 27.43B | 6.58B | 2.71B |
| Sep 30, 2023 | 25.48B | 5.68B | 2.76B |
| Jun 30, 2023 | 24.46B | 4.42B | 2.95B |
| Mar 31, 2023 | 23.28B | 3.37B | 3.12B |
| Dec 31, 2022 | 22.07B | 2.67B | 3.25B |
| Sep 30, 2022 | 21.02B | 2.19B | 3.23B |
| Jun 30, 2022 | 19.85B | 1.88B | 3.13B |
| Mar 31, 2022 | 18.85B | 1.62B | 3.10B |
| Dec 31, 2021 | 17.90B | 1.33B | 3.04B |
| Sep 30, 2021 | 16.70B | 1.13B | 3.00B |
| Jun 30, 2021 | 15.92B | 982.87M | 3.04B |
| Mar 31, 2021 | 15.60B | 895.91M | 3.02B |
| Dec 31, 2020 | 15.36B | 897.96M | 3.03B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.